Central Bank & Trust’s Radius Health, Inc. RDUS Stock Holding History

Central Bank & Trust’s Portfolio RDUS Stock Details RDUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-200	Closed	-$2K	–	337
2022 Q2	$2K	Hold	200	–	–	﹤0.01%	315
2022 Q1	$2K	Hold	200	–	–	﹤0.01%	312
2021 Q4	$1K	Hold	200	–	–	﹤0.01%	319
2021 Q3	$2K	Hold	200	–	–	﹤0.01%	299
2021 Q2	$4K	Hold	200	–	–	﹤0.01%	288
2021 Q1	$4K	Hold	200	–	–	﹤0.01%	280
2020 Q4	$4K	Hold	200	–	–	﹤0.01%	268
2020 Q3	$2K	Hold	200	–	–	﹤0.01%	298
2020 Q2	$3K	Hold	200	–	–	﹤0.01%	248
2020 Q1	$3K	Hold	200	–	–	﹤0.01%	244
2019 Q4	$4K	Hold	200	–	–	﹤0.01%	251
2019 Q3	$5K	Buy	+200	New	+$4.9K	﹤0.01%	266

Other funds holding RDUS

RCG

Rock Creek Group Washington, District of Columbia $988M AUM 8.89% 1-Year Est. Return

Central Bank & Trust's RDUS Position: Q3 2022 in Review

Central Bank & Trust sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 200 shares — an estimated $2K sold.

Central Bank & Trust first reported a position in RDUS in Q3 2019 and held it in 12 quarters. The position peaked at $5K in Q3 2019. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.

Central Bank & Trust reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
Central Bank & Trust sold 200 Radius Health, Inc. shares in Q3 2022, an estimated $2K.
Central Bank & Trust first reported a position in Radius Health, Inc. in Q3 2019 and held it in 12 quarters.
Central Bank & Trust's Radius Health, Inc. position peaked at $5K in Q3 2019.
1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.

Based on Central Bank & Trust's 13F filing for Q3 2022, filed 20 Oct 2022.